Amarin Pharma Inc. v. International Trade Commission

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term
19-152 Fed. Cir. TBD TBD TBD TBD TBD

Issue: Whether, when a manufacturer files a Lanham Act claim under the Tariff Act for competitive injuries caused by unfair trade practices, the claim is barred as a matter of law when the International Trade Commission would need to consider the meaning of terms used in the Food, Drug and Cosmetic Act in order to determine whether the claim has merit.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
Jul 30 2019Petition for a writ of certiorari filed. (Response due September 3, 2019)
Aug 27 2019Motion of International Trade Commission, et al. for an extension of time not accepted for filing. (August 28, 2019 - Corrected motion to be filed)
Aug 28 2019Motion to extend the time to file a response from September 3, 2019 to October 3, 2019, submitted to The Clerk.
Aug 30 2019Motion to extend the time to file a response is granted and the time is extended to and including October 3, 2019, for all respondents.
Term Snapshot
At a Glance